- Record: found
- Abstract: found
- Article: not found
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes.
E J Lewis
1 ,
L G Hunsicker ,
W R Clarke ,
T Berl ,
M A Pohl ,
J B Lewis ,
E Ritz ,
R C Atkins ,
R Rohde ,
I Raz
Sep 20 2001
Read this article at
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
It is unknown whether either the angiotensin-II-receptor blocker irbesartan or the calcium-channel blocker amlodipine slows the progression of nephropathy in patients with type 2 diabetes independently of its capacity to lower the systemic blood pressure.